Clinical trials
Completed Myofascial Pain Syndromes trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
174 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 6 |
| 2015 | 2 |
| 2016 | 9 |
| 2017 | 13 |
| 2018 | 9 |
| 2019 | 18 |
| 2020 | 17 |
| 2021 | 24 |
| 2022 | 17 |
| 2023 | 11 |
| 2024 | 13 |
| 2025 | 15 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 174 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Riphah International University | 13 |
| Cairo University | 6 |
| University of Alcala | 6 |
| Mayuben Private Clinic | 4 |
| Ankara University | 3 |
| Istanbul Training and Research Hospital | 3 |
| King Saud University | 3 |
| Abant Izzet Baysal University | 2 |
| Bahçeşehir University | 2 |
| Bursa Yuksek Ihtisas Training and Research Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myofascial Pain Syndromes | 174 |
| Neck Pain | 22 |
| Pain | 18 |
| Fibromyalgia | 8 |
| Temporomandibular Joint Disorders | 7 |
| Chronic Pain | 6 |
| Low Back Pain | 6 |
| Myalgia | 5 |
| Agnosia | 3 |
| Shoulder Pain | 3 |
Trials
Showing 1 to 25 of 174. Each trial links to its page on Pharma Observatory.
74 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.